Home / ATX.AX : ASX

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ATX.AX make money? Does ATX.AX have pricing power? What's the Earnings Whisper? Will ATX.AX profit more as the business scales? What is ATX.AX's management track record? Is ATX.AX's current price justified?

Amplia Therapeutics Limited

AUD 0.12 -$0.05 (-26.47%)

ASX · 16 Sep 2026 01:59 UTC

Previous Close

AUD 0.12

Day Range

AUD 0.12 - AUD 0.12

Year Range

AUD 0.1AUD 0.28

Market Cap

64.16M

AVG Volume

1.12M

Trailing/Forward PE

-7.49/-

PEG ratio

0.11

Dividend Yield

Next Earnings Date

2026-11-27

Primary Exchange

Australian Securities Exchange

Net Income (AUD)

ATX.AX Net Income (AUD) by year
Period	Net Income (AUD)
2013	-3.39M

Operating Income (AUD)

ATX.AX Operating Income (AUD) by year
Period	Operating Income (AUD)
2013	-3.03M

EBITDA (AUD)

ATX.AX EBITDA (AUD) by year
Period	EBITDA (AUD)
2013	-1.48M

Cash Flows (AUD)

ATX.AX Cash Flows (AUD) by year
Period	Cash Flows (AUD)
2013	-1.75M

EPS (AUD)

ATX.AX EPS (AUD) by year
Period	EPS (AUD)
2013	-0.2

Expenses (AUD)

ATX.AX Expenses (AUD) by year
Period	Expenses (AUD)
2013	1.71M

Cash & Debt (AUD)

ATX.AX Cash & Debt (AUD) by year
Period	Cash & Debt (AUD)
2013	8.36M

Debt ratios

ATX.AX Debt ratios by year
Period	Debt ratios
2013	43.76

Return on Capital

ATX.AX Return on Capital by year
Period	Return on Capital
2013	-30.16%

Shares Outstanding

ATX.AX Shares Outstanding by year
Period	Shares Outstanding
2013	17.32M

Book Value Per Share (AUD)

ATX.AX Book Value Per Share (AUD) by year
Period	Book Value Per Share (AUD)
2013	0.65

Total Assets (AUD)

ATX.AX Total Assets (AUD) by year
Period	Total Assets (AUD)
2013	11.43M

Free Cash Flow Yield

ATX.AX Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-25.43%
Sep 26	-25.43%
Sep 26	-23.47%
Aug 26	-21.04%
Aug 26	-20.34%
Aug 26	-21.04%
Aug 26	-20.34%
Jul 26	-23.47%
Jul 26	-21.79%
Jul 26	-22.6%
Jul 26	-21.04%
Jul 26	-20.34%
Jun 26	-28.05%
Jun 26	-32.93%
Jun 26	-34.42%
Jun 26	-31.55%
May 26	-28.05%
May 26	-29.13%
May 26	-25.24%
May 26	-29.13%
May 26	-25.24%
Apr 26	-22.95%
Apr 26	-22.95%
Apr 26	-24.43%
Apr 26	-15.78%
Mar 26	-15.78%
Mar 26	-16.11%
Mar 26	-32.93%
Mar 26	-34.42%
Feb 26	-31.55%
Feb 26	-30.29%
Feb 26	-30.29%
Feb 26	-31.55%
Jan 26	-29.13%
Jan 26	-29.13%
Jan 26	-23.67%
Jan 26	-21.64%
Jan 26	-22.27%
Dec 25	-26.65%
Dec 25	-26.65%
Dec 25	-25.63%
Dec 25	-26.65%
Nov 25	-24.68%
Nov 25	-28.97%
Nov 25	-25.63%
Nov 25	-25.63%
Oct 25	-23.8%
Oct 25	-25.63%
Oct 25	-22.21%
Oct 25	-22.21%
Oct 25	-19.04%
Sep 25	-22.21%
Sep 25	-18.51%
Sep 25	-20.19%
Sep 25	-21.49%
Aug 25	-20.19%
Aug 25	-18.01%
Aug 25	-16.66%
Aug 25	-16.25%
Aug 25	-14.49%
Jul 25	-13.6%
Jul 25	-11.69%
Jul 25	-9.52%
Jul 25	-11.29%
Jun 25	-15.52%
Jun 25	-16.66%
Jun 25	-59.92%
Jun 25	-51.75%
May 25	-68.31%
May 25	-68.31%
May 25	-52.54%
May 25	-63.25%
May 25	-62.1%
Apr 25	-66.97%
Apr 25	-65.68%
Apr 25	-65.68%
Apr 25	-56.92%
Mar 25	-48.79%
Mar 25	-43.79%
Mar 25	-48.1%
Mar 25	-46.78%
Feb 25	-43.79%
Feb 25	-41.65%
Feb 25	-40.66%
Feb 25	-40.18%
Jan 25	-39.26%
Jan 25	-41.65%
Jan 25	-40.66%
Jan 25	-40.18%
Jan 25	-36.33%
Dec 24	-64.12%
Dec 24	-64.89%
Dec 24	-62.62%
Dec 24	-61.9%
Nov 24	-61.2%
Nov 24	-61.2%
Nov 24	-54.96%
Nov 24	-57.91%
Nov 24	-46.83%
Oct 24	-37.14%

Price to Sales

ATX.AX Price to Sales by year
Period	Price to Sales
Sep 26	16.27
Sep 26	16.27
Sep 26	17.63
Aug 26	19.66
Aug 26	20.34
Aug 26	19.66
Aug 26	20.34
Jul 26	17.63
Jul 26	18.98
Jul 26	18.31
Jul 26	19.66
Jul 26	20.34
Jun 26	9.95
Jun 26	8.47
Jun 26	8.1
Jun 26	8.84
May 26	9.95
May 26	9.58
May 26	11.05
May 26	9.58
May 26	11.05
Apr 26	12.16
Apr 26	12.16
Apr 26	11.42
Apr 26	17.68
Mar 26	17.68
Mar 26	17.31
Mar 26	8.47
Mar 26	8.1
Feb 26	8.84
Feb 26	9.21
Feb 26	9.21
Feb 26	8.84
Jan 26	9.58
Jan 26	9.58
Jan 26	11.79
Jan 26	12.89
Jan 26	12.53
Dec 25	5.47
Dec 25	5.47
Dec 25	5.69
Dec 25	5.47
Nov 25	5.91
Nov 25	5.04
Nov 25	5.69
Nov 25	5.69
Oct 25	6.13
Oct 25	5.69
Oct 25	6.57
Oct 25	6.57
Oct 25	7.66
Sep 25	6.57
Sep 25	7.88
Sep 25	7.23
Sep 25	6.79
Aug 25	7.23
Aug 25	8.1
Aug 25	8.76
Aug 25	8.98
Aug 25	10.07
Jul 25	10.73
Jul 25	12.48
Jul 25	15.33
Jul 25	12.92
Jun 25	10.57
Jun 25	9.84
Jun 25	2.74
Jun 25	3.17
May 25	2.4
May 25	2.4
May 25	3.12
May 25	2.59
May 25	2.64
Apr 25	2.45
Apr 25	2.5
Apr 25	2.5
Apr 25	2.88
Mar 25	3.36
Mar 25	3.75
Mar 25	3.41
Mar 25	3.51
Feb 25	3.75
Feb 25	3.94
Feb 25	4.03
Feb 25	4.08
Jan 25	4.18
Jan 25	3.94
Jan 25	4.03
Jan 25	4.08
Jan 25	4.51
Dec 24	2.89
Dec 24	2.85
Dec 24	2.95
Dec 24	2.99
Nov 24	3.02
Nov 24	3.02
Nov 24	3.37
Nov 24	3.19
Nov 24	3.95
Oct 24	4.98

Price to Book

ATX.AX Price to Book by year
Period	Price to Book
Sep 26	1.56
Sep 26	1.56
Sep 26	1.69
Aug 26	1.88
Aug 26	1.95
Aug 26	1.88
Aug 26	1.95
Jul 26	1.69
Jul 26	1.82
Jul 26	1.75
Jul 26	1.88
Jul 26	1.95
Jun 26	1.34
Jun 26	1.14
Jun 26	1.09
Jun 26	1.19
May 26	1.34
May 26	1.29
May 26	1.49
May 26	1.29
May 26	1.49
Apr 26	1.64
Apr 26	1.64
Apr 26	1.54
Apr 26	2.38
Mar 26	2.38
Mar 26	2.33
Mar 26	1.14
Mar 26	1.09
Feb 26	1.19
Feb 26	1.24
Feb 26	1.24
Feb 26	1.19
Jan 26	1.29
Jan 26	1.29
Jan 26	1.59
Jan 26	1.74
Jan 26	1.69
Dec 25	2.14
Dec 25	2.14
Dec 25	2.23
Dec 25	2.14
Nov 25	2.32
Nov 25	1.97
Nov 25	2.23
Nov 25	2.23
Oct 25	2.4
Oct 25	2.23
Oct 25	2.57
Oct 25	2.57
Oct 25	3
Sep 25	2.57
Sep 25	3.09
Sep 25	2.83
Sep 25	2.66
Aug 25	2.83
Aug 25	3.17
Aug 25	3.43
Aug 25	3.52
Aug 25	3.95
Jul 25	4.2
Jul 25	4.89
Jul 25	6
Jul 25	5.06
Jun 25	4.37
Jun 25	4.07
Jun 25	1.13
Jun 25	1.31
May 25	0.99
May 25	0.99
May 25	1.29
May 25	1.07
May 25	1.09
Apr 25	1.01
Apr 25	1.03
Apr 25	1.03
Apr 25	1.19
Mar 25	1.39
Mar 25	1.55
Mar 25	1.41
Mar 25	1.45
Feb 25	1.55
Feb 25	1.63
Feb 25	1.67
Feb 25	1.69
Jan 25	1.73
Jan 25	1.63
Jan 25	1.67
Jan 25	1.69
Jan 25	1.87
Dec 24	1.43
Dec 24	1.41
Dec 24	1.46
Dec 24	1.48
Nov 24	1.49
Nov 24	1.49
Nov 24	1.66
Nov 24	1.58
Nov 24	1.95
Oct 24	2.46

No video analysis for this stock yet. Request one from our team.

News: ATX.AX

proactiveinvestors.com · 4 Aug 2026

Amplia Therapeutics partners with Lilly on lung cancer combination trial

Amplia Therapeutics Ltd (ASX:ATX, OTCQB:INNMF) has signed a clinical collaboration agreement with Eli Lilly and Company to evaluate its lead drug...

AI Analysis

Amplia Therapeutics Limited

Video analysis: ATX.AX

News: ATX.AX

Amplia Therapeutics partners with Lilly on lung cancer combination trial

Similar companies